Maxitrol

Neomycin / Polymyxin B / Dexamethasone, the active ingredient in Maxitrol, is a corticosteroid/aminoglycoside antibiotic/polymyxin antibiotic combination presented as an ophthalmic suspension for ocular use. It treats bacterial conjunctivitis, post‑operative ocular inflammation, allergic conjunctivitis and other inflammatory eye conditions by reducing inflammation and eliminating susceptible bacteria.

GNH USA supplies Maxitrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches for global distribution.

Maxitrol is used to manage ocular conditions involving bacterial infection and inflammation.

Bacterial conjunctivitis: reduces bacterial load and alleviates redness, discharge and discomfort. Post‑operative ocular inflammation: controls inflammation and helps prevent infection after eye surgery. Allergic conjunctivitis: diminishes allergic inflammatory response and provides symptomatic relief.

Adverse ocular reactions may occur with Maxitrol use.

Common Side Effects: - Stinging or burning sensation upon instillation - Transient blurred vision - Eye redness (hyperemia) - Increased intra‑ocular pressure - Mild ocular irritation or itching - Tearing

Serious or Rare Side Effects: - Allergic reaction such as swelling, rash or urticaria - Secondary ocular infection or worsening of infection - Corneal ulceration or thinning - Development of cataract with prolonged use - Glaucoma due to sustained pressure rise - Systemic corticosteroid effects from excessive absorption

Before prescribing Maxitrol, consider the following precautions.

Assess for viral or fungal eye infection: avoid use if such infection is present. Monitor intra‑ocular pressure: especially in patients with glaucoma or ocular hypertension. Check for hypersensitivity: discontinue if any allergic response to the components occurs. Limit duration of therapy: use only under ophthalmologist supervision to prevent complications. Pregnancy and lactation: safety not established; use only if potential benefit outweighs risk. Store at room temperature: keep in original container, protect from light and moisture.

Maxitrol may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic glucocorticoid effects. - Concurrent ophthalmic antibiotics: can lead to additive ocular toxicity. - Anticholinergic eye drops: may reduce the anti‑inflammatory efficacy.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may increase ocular irritation. - Contact lens wear: lenses can trap the suspension, increasing exposure and risk of irritation.